Vasoconstrictive drugs increase carbonic anhydrase I in vascular smooth muscle while vasodilating drugs reduce the activity of this isozyme by a direct mechanism of action

Drugs under Experimental and Clinical Research

Volumn 27, Issue 2, 2001, Pages 53-60

  Puscas, Ioan ^a,e   Coltau, M ^b   Baican, M ^c   Pasca, R ^b   Domuta, G ^b   Hecht, A ^d  

^a UNIVERSITY OF ORADEA   (Romania)

^b ACADEMY OF ROMANIAN SCIENTISTS   (Romania)

^c Klinik Wilkenberg   (Germany)

^d Medical Care Unit   (United States)

^e Ctr for Res and Medical Assistance   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMLODIPINE; ANGIOTENSIN; CARBONATE DEHYDRATASE; CLONIDINE; DESMOPRESSIN; FUROMEX; FUROSEMIDE; HYDRALAZINE; INDAPAMIDE; INDOMETACIN; IRBESARTAN; ISOENZYME; LEUKOTRIENE B4; NORADRENALIN; ORCIPRENALINE; PRAZOSIN; PROSTACYCLIN; PROSTAGLANDIN F2 ALPHA; RESERPINE; THROMBOXANE A2; VASOCONSTRICTOR AGENT; VASODILATOR AGENT; VASOPRESSIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PH; RABBIT; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CARBONIC ANHYDRASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MUSCLE, SMOOTH, VASCULAR; RABBITS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0035008544     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Marer T.H. Carbonic anhydrase: Chemistry, physiology and inhibition. Physiol. Rev., 47, 595, 1967.
2. Carter M.J. Carbonic anhydrase: Isoenzymes, properties, distribution and functional significance. Bio. Rev., 47, 465, 1972.
3. Sly W.S., H.I.P.Y. Human carbonic anhydrases and carbonic anhydrase deficiences. Annu. Rev. Biochem., 64, 375, 1995.
4. Tashian R.E. The carbonic anhydrases: Widening perspectives on their evolution, expression and function. BioEssays, 10, 186, 1989.
5. Vandenberg J.I., Carter N.D., Bethell H.W.L., et al. Carbonic anhydrase and cardiac pH regulation. Am. J. Physiol., 271, 1838, 1996.
6. Whitney P.L., Briggle T.V. Membrane-associated carbonic anhydrase purified from bovine lung. J. Biol. Chem., 257, 12056, 1982.
7. Wistrand P.J., Knuuttila K.G. Renal membrane-bound carbonic anhydrase. Purification and properties. Kidney Int., 35, 851, 1989.
8. Zhu X.L., Sly W.S. Carbonic anhydrase IV from human lung. Purification, characterization, and comparison with membrane carbonic anhydrase from human kidney. J. Biol. Chem., 265, 8795, 1990.
9. Lonnerholm G., Selking O., Wistrand P.J. Amount and distribution of carbonic anhydrases I and II in the gastrointestinal tract. Gastroenterology, 86, 1151, 1985.
10. Puscas I., Vlaicu R., Lazar A. Isosorbide nitrates nitroglycerine and sodium nitroprusside induce vasodilation, concomitantly with inhibition of carbonic anhydrase I in erythrocytes. Am. J. Hypertens., 10 (1), 124, 1997.
11. Puscas I., Coltau M. Inhibition of carbonic anhydrase by nitric oxide. Arzneimittel Forschung/Drug Research, 8, 846, 1995.
12. Puscas I., Coltau M., Pasca R. Nonsteroidal anti-inflammatory drugs activate carbonic anhydrase by a direct mechanism of action. J. Pharmacol. Exp. Therap. USA, 277 (3), 1146, 1996.
13. 4 increase carbonic anhydrase activity. Int. J. Clin. Pharmacol. Therapeutics, 32 (3) 176, 1995.
14. Puscas I., Coltau M., Baican M., Domuta G., Hecht A. Vasodilatory effect of diuretics is dependent on inhibition of vascular smooth muscle carbonic anhydrase by a direct mechanism of action. Drugs Exptl. Clin. Res., 25 (6), 271, 1999.
15. Puscas I., Coltau M., Domuta G., Baican M., Puscas C., Pasca R. Carbonic anhydrase / inhibition by nitric oxide: Implications for mediation of the hypercapnia-induced vasodilator response. Clin. Exp. Pharmacol. Physiol., 27, 95, 2000.
16. Chegwidden W.R. Purifiaction of the carbonic anhydrases. In: Dogson S.J., Thashian R.E., Gros G., Carter D.N. (Eds.). "The Carbonic Anhydrases: Cellular Physiology and Molecular Genetics". Plenum Press, New York, 1988, pp. 101-117.
17. Khalifah R.G. The carbon dioxide hidration activity of carbonic anhydrase: Stop-flow kinetic studies on the native human isozymes B and C. J. Biol. Chem., 246, 2561, 1971.
18. Tashian R.E., Hewett-Emmett D., Goodman M. Diversity and evolution in the carbonic anhydrase gene family. In: Botre F., Gros G., Storey B.T. (Eds.). "Carbonic Anhydrase. From Biochemistry and Genetics to Physiology and Clinical Medicine". V.C.H. Weinheim, 1991, pp. 151-161.
19. 1-equilibria in the body. In: Hausinger D. (Ed.). "pH Homeostasis". Academic Press, New York, 1988, pp. 203-231.
20. Ilurriaga R., Lahin S., Mokash A. Carbonic anhydrase and chemoreception in the cat carotid body. Am. J. Physiol., 261, 565, 1991.
21. Lahin S. Carbonic anhydrase and chemoreception in carotid and aortic bodies. In: Dogson S.J., Thashian R.E., Gros G., Carter D.N. (Eds.). "The Carbonic Anhydrases: Cellular Physiology and Molecular Genetics". Plenum Press, New York, 1991, pp. 341-344.
22. Chen J.C., Chesler M. pH transients evoked by excitatory synaptic transmission are increased by inhibition of extracellular carbonic anhydrase. Proc. Natl. Acad. Sci. USA, 89, 7786, 1992.
23. Gilmour K.M. The disequilibrium pH: A tool for the localization of carbonic anhydrase. Biochem. Physiol., 119 (1), 243, 1998.
24. Puscas I. Carbonic anhydrase and vascular endothelium. In: Puscas I. (Ed.). "Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism". Helicon Publishing House, Timisoara, 1994, pp. 197-306.
25. Puscas I., Supuran C.T. Carbonic anhydrase is an important physiological modulator. pH Theory. In: Puscas I. (Ed.). "Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism". Helicon Publishing House, Timisoara, 1994, pp. 147-165.
26. Batlle D.C., Saleh A., Rombola G. Reduced intracellular pH in lymphocytes from the spontaneously hypertensive rat. Hypertension, 15, 97, 1990.
27. Batlle D., Sharma A.M., Alsheikha M.W., Sobrero M., Saleh A., Gutterman C. Renal acid excretion and intracellular pH in salt-sensitive genetic hypertension. J. Clin. Invest., 91, 2178, 1993.
28. - antiporter of lymphocites from the spontaneously hypertensive rat: Role of intracellular pH. J. Clin. Invest., 85, 1734, 1990.
29. Resnick L.M., Gupta R.K., Sosa R.E., et al. Intracellular pH in human and experimental hypertension. Proc. Natl. Acad. Sci. USA, 84, 7663, 1987.
30. Aalkjaer C., Poston L. Effects of pH on vascular tension: Which are the important mechanisms? J. Vasc. Res., 33, 347, 1996.
31. 2 on limb, renal and coronary vascular resistances. Am. J. Physiol., 213, 1102, 1967.
32. Kontos H.A., Richardson D.W., Patterson J.L. Effects of hypercapnia in human forearm blood vessels. Am. J. Physiol., 212, 1070, 1967.
33. Aalkjaer C., Cragoe E.J.J. intracellular pH regulation in resting and contracting segments of rat mesenteric resistance vessels. J. Physiol., 402, 391, 1988.
34. 1 and tension in isolated rat mesenteric resistance arteries. J. Vasc. Res., 29, 330, 1992.
35. Ighoroje A.D., Spurway N.C. Procedures to acidify cytoplasm raise the tone of isolated (rabbit ear) blood vessels. J. Physiol., 357, 105, 1984.
36. 2+] in porcine coronary artery smooth muscle. Circ.Res., 75, 990, 1994.
37. 4-induced swine carotid artery contraction. Hypertension, 25, 482, 1995.
38. Krampetz I.K., Rhoades R.A. Intracellular pH: Effect of pulmonary arterial smooth muscle. Am. J. Physiol., 260, 516, 1991.
39. 4Cl on the contractility of isolated vascular smooth muscle. Life Sci., 41, 95, 1987.